World Library  
Flag as Inappropriate
Email this Article

Pharmaceutical Product Development

 

Pharmaceutical Product Development

Pharmaceutical Product Development, LLC.
Type Private
Industry Contract research organizations
Pharmaceutical
Biotechnology
Founded 1985
Headquarters Wilmington, North Carolina, United States
Key people See Principal Officers page of the PPD Website[1]
Products Contract clinical research for pharmaceutical, biotechnology, medical device, academic and government organizations; services include discovery, development, lifecycle management and laboratory services.
Employees 13,000 (2014)
Website www.ppdi.com

Pharmaceutical Product Development, LLC (PPD) is a global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. The company’s clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. PPD is mainly known for conducting drug development for its clients, it also invests in developing new products through its compound partnering program.

Contents

  • History 1
  • Location 2
  • Operations 3
  • Clinical Development Services 4
  • Laboratory Services 5
  • Discovery Sciences/Compound Partnering 6
  • References 7
  • External links 8

History

PPD was founded by Fred Eshelman, Pharm.D., as a one-person consulting firm in 1985. The following year he expanded the company's scope to include development services and relocated operations from Maryland to North Carolina.

Location

PPD maintains its worldwide headquarters in Wilmington, N.C. The company has approximately 13,000 employees and offices in 46 countries.

Operations

PPD provides drug discovery, development, lifecycle management and laboratory services. PPD has a 300-bed healthy volunteer (Phase I) clinic and a dental research clinic in Austin, Texas.

Clinical Development Services

PPD provides product development and post-approval services for biopharmaceuticals and devices, as well as full service Phase II-IIIb clinical studies for multinational regulatory submissions. PPD also offers clinical data management and information solutions, including consulting and proprietary software tools to speed collection, analysis and reporting of clinical trial data.

Laboratory Services

PPD provides bioanalytical, cGMP product analysis, central laboratory, and vaccines and biologics lab services.

Discovery Sciences/Compound Partnering

The discovery sciences segment offers biomarker discovery services, nonclinical development and preclinical services. Through its compound partnering program, it also seeks to in-license early-stage compounds, take them through proof of concept, and out-license them to its partners for late clinical testing and commercialization. PPD shares in the risks and rewards of bringing a drug to market, gaining revenues generated by licensing fees, milestone payments and commercial royalties.

The company’s post-approval services include epidemiology, risk management and outcomes research; late-stage trials; medical information; product safety; registries and observational studies.

References

  1. ^ http://www.ppdi.com/About/Principal-Officers.aspx

External links

  • PPD official Website
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.